drugset / Press release
Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7)
2012-02-28 · Ultragenyx Pharmaceutical Inc · original ultragenyx.com ↗
Ultragenyx Granted Orphan Drug Designation for UX003 for the Treatment of Mucopolysaccharidosis Type 7 (MPS 7)
The release as fetched from its publisher. ultragenyx.com ↗